Current Report Filing (8-k)
November 07 2018 - 4:11PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________
FORM 8-K
____________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event
reported): November 7, 2018 (November 7, 2018)
____________________
Global
Medical REIT Inc.
(Exact name of registrant as specified in its charter)
____________________
Maryland
|
001-37815
|
46-4757266
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
2 Bethesda Metro Center, Suite 440
Bethesda, MD
20814
|
|
|
(Address of Principal Executive Offices)
(Zip Code)
|
|
|
|
|
|
(202) 524-6851
|
|
(Registrant’s Telephone Number, Including
Area Code)
Not Applicable
(Former name
or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 7.01 Regulation FD Disclosure.
On November 7, 2018,
Global Medical REIT Inc. (the “Company”) updated an investor presentation concerning the Company on its website, www.globalmedicalreit.com,
on the “Investors” page. A copy of the investor presentation is furnished as Exhibit 99.1 to this Current Report on
Form 8-K and is incorporated herein solely for purposes of this Item 7.01 disclosure.
Such investor presentation
shall not be deemed “filed” for any purpose, including for the purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information
in this Item 7.01, as well as Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities
Act of 1933, as amended, or the Exchange Act regardless of any general incorporation language in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Global Medical REIT Inc.
|
|
|
|
|
By:
|
/s/ Jamie A. Barber
|
|
|
Jamie A. Barber
|
|
|
Secretary and General Counsel
|
|
|
|
Dated: November 7, 2018
|
|
|
Global Med REIT (NYSE:GMRE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Global Med REIT (NYSE:GMRE)
Historical Stock Chart
From Jul 2023 to Jul 2024